Skip to content
Aussie8 – Lifestyle
Author:
SYSTIMMUNE.INC
New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
May 21, 2026
SystImmune, Inc. to Present New iza-bren (izalontamab brengitecan) Data in Extensive Stage Small Cell Lung Cancer at ELCC 2026
March 18, 2026